ScholarIQanswers from OpenAlex

Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy

PaperCitations, authors & open-access status

Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy have?

ScholarIQcitation count

Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy has 219 citations in the OpenAlex counts ScholarIQ stores.

When was Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy published?

ScholarIQyear

Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy has 2008 year in the ScholarIQ index.

What is the open-access status of Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy?

ScholarIQoa status

Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy has closed oa status in the ScholarIQ index.

What is the DOI of Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy?

ScholarIQdoi

The DOI for Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy is on the source record.

What is the PMID of Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy?

ScholarIQpmid

The PMID for Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy is on the source record.

What is the OpenAlex record for Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy?

ScholarIQopenalex

The OpenAlex for Common femoral artery occlusive disease: Contemporary results following surgical endarterectomy is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial